Social Sentiment for RKDA
Bullish vs. Bearish opinions
Weighted Sentiment 0.05
Arcadia Biosciences Forecast and Stock Analysis
Technical RKDA stock analysis for Monday June 24, 2019.
Arcadia Biosciences fell by -6.94% in the last day ( Monday, 24th Jun 2019 ) from $3.60 to $3.35 and has now fallen 5 days in a row. During day the stock fluctuated 11.25% from a day low at $3.30 to a day high of $3.67. The price has fallen in 8 of the last 10 days and is down by -32.73% for this period. Volume has increased in the last day by 56 275 shares, but on falling prices. This may be an early warning and the risk will be increased slightly for the next couple of days. In total, 173 209 shares bought and sold for approximately $580 250.00.
- 30 day high of the RKDA stock price was $6.47 and low was $3.30.
- 90 day high was $7.83 and low was $3.30.
- 52 week high for the Arcadia Biosciences - $10.40 and low - $2.65.
Arcadia Biosciences has broken the very wide and falling short-term trend down. Firstly a stronger fallrate is indicated, but false breaks and "sell-off" may occur. However, a further fall is realistic and any reactions back to the breaking point ($3.41) are considered to be a "second chance" to get out. According to the fan-theory $1.34 will represent the new bottom line of the next trend, but it is far too early to say this for certain.
There are few to none technical positive signals at the moment. Arcadia Biosciences holds sales signals from both short- and long-term moving averages. In addition, there is a general sales signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up there will be some resistance from the lines at $3.67 and $4.79. A break-up above any of these levels will issue buy signals. A sales signal was issued from a pivot top point on Wednesday June 12, 2019, which indicates further falls until a new bottom pivot has been found. Arcadia Biosciences gained volume on the last day, but on falling prices. In technical terms this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-off's".
Relative Strength Index (RSI)
RSI14 is 31 and the stock is currently not being overbought or oversold
Support & Resistance
There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.
This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.37 between high and low, or 11.25%. For the last week, the stock has had a daily average volatility of 7.07%.
Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.
7.07 %Average volatility
Very Low Low Medium High Very High
Arcadia Biosciences holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our recommendation for this stock since last evaluation from a Sell Candidate to a Strong Sell Candidate.
|Golden Star Signal|
Get competitive edge
The signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives a very good return. From 8.000 stocks usually only a few will trigger a Golden Star Signal per day!
Get access to Golden Star list now
From Our Blog
- Trading With Moving Average
- Pivot Points
- Accumulated Volume - Support and Resistance
- Volume - The Indicator You Really Need to Know
- We Give Back!
- Better Buy: Amazon vs. Facebook
- Better Buy: Apple vs. Microsoft
- Relative Strength Index (RSI)
- How to Lose Money When Trading: Part 2
- How to Lose Money When Trading: A Trader is Born
- Our 2017 Christmas Donation
- The Golden Star
- Announcing Partnership With CityFALCON
- Why correct moving average matters
- NASDAQ down -4.17%. Our portfolio is up +8.56%
- New Feature Added: Golden Star Signal
- Pick a Winner With StockInvest.us